-
-
-
-
-
-
-
Context Therapeutics Inc. (CNTX) Misses Q3 EPS by 1c
-
-
-
-
-
-
-
Context Therapeutics (CNTX) Appoint Dr. Karen Chagin as Chief Medical Officer
-
-
-
-
-
-
-
Context Therapeutics (CNTX) Announces First Patient Dosed in the Phase 1 Clinical Trial of CTIM-76
-
-
-
-
-
-
-
Piper Sandler Reiterates Overweight Rating on Context Therapeutics (CNTX)
-
-
-
-
-
-
416,807 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

